On September 30, 2026, FMR LLC sold 83,000 shares of Consun Pharmaceutical Group Ltd. (01681) on the SEHK open market at an average of HKD 14.5448 per share, involving about HKD 1.21 million. This is an on-exchange active trade, a direct dealing in the secondary market.
Prior to the disposal, FMR LLC's long position in CONSUN PHARMA was 75.82 million shares, representing 9.01%; following the disposal, the holding changed to 75.73 million shares, with the long position ratio falling to 8.99%.